MedPath

Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

Not Applicable
Recruiting
Conditions
Overweight and Obesity
Registration Number
NCT05107908
Lead Sponsor
University of Colorado, Denver
Brief Summary

The purpose of this study is to determine how different behavioral interventions designed to alter food perceptions and behaviors affect brain responses to food, eating behaviors, and body weight.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
228
Inclusion Criteria
  • 18-65 years old
  • BMI of 27 or greater
Exclusion Criteria
  • MRI contraindications (e.g., metal or electronic devices in the body)
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percent Change in Blood Oxygen Level Dependent (BOLD) Response to Visual Food Cues as Measured by Functional Magnetic Resonance ImagingBaseline, 12 weeks

Percent change in blood oxygen level dependent (BOLD) response from baseline to after the 12-week intervention while viewing visual food cues will be measured using functional magnetic resonance imaging (fMRI), focusing on insula, striatum, and prefrontal cortex.

Change in Food Image RatingsBaseline, 12 weeks

Food image ratings change from baseline to after the 12-week intervention. Food images are rated on "desire to eat" by visual analogue scale (0-100), with higher scores indicating greater desire to eat.

Change in Food IntakeBaseline, 12 weeks

Food intake change from baseline to after the 12-week intervention. Food intake will be measured as total calories consumed during an ad libitum meal.

Secondary Outcome Measures
NameTimeMethod
Percent Change in Body WeightBaseline, 12 weeks

Percent change in body weight (kg) from baseline to after the 12-week intervention.

Change in Fat MassBaseline, 12 weeks

Change in fat mass, as measured using dual-energy x-ray absorptiometry, from baseline to after the 12-week intervention.

Trial Locations

Locations (1)

University of Colorado Anschutz Medical Campus

🇺🇸

Aurora, Colorado, United States

University of Colorado Anschutz Medical Campus
🇺🇸Aurora, Colorado, United States
Christina Erpelding, BS
Contact
303-724-8502
christina.erpelding@cuanschutz.edu
Kristina Legget, PhD
Contact
303-724-5809
kristina.legget@cuanschutz.edu
Jason Tregellas, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.